{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:52:49Z","timestamp":1789944769980,"version":"4.0.1"},"reference-count":112,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NARSAD Independent Investigator Grant from the Brain and Behavioural Research Foundation (AG)"},{"name":"Ontario Early Researcher Award (AG)"},{"name":"CIHR fellowship award (SN)"}],"content-domain":{"domain":["schres-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.schres.2015.01.043","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T22:16:40Z","timestamp":1423865800000},"page":"164-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Neuroimaging findings in treatment-resistant schizophrenia: A systematic review"],"prefix":"10.1016","volume":"164","author":[{"given":"Shinichiro","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Plitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan","family":"Fervaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gerretsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Caravaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Ku","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.yco.0000214337.29378.cd","article-title":"What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update","volume":"19","author":"Abbott","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2006.01.019","article-title":"The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm","volume":"169","author":"Abdul-Monim","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00210-006-0115-9","article-title":"Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex","volume":"374","author":"Abekawa","year":"2006","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.schres.2015.01.043_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00210-007-0154-x","article-title":"Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic","volume":"375","author":"Abekawa","year":"2007","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.schres.2015.01.043_bb0025","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"14","key":"10.1016\/j.schres.2015.01.043_bb0030","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.schres.2015.01.043_bb0035","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4088\/JCP.09m05785yel","article-title":"An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis","volume":"72","author":"Agid","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.01.043_bb0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-007-0808-x","article-title":"Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats","volume":"193","author":"Amitai","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0040","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.neuropharm.2011.01.008","article-title":"Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats","volume":"62","author":"Amitai","year":"2012","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.schres.2015.01.043_bb0050","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1176\/appi.ajp.160.8.1421","article-title":"The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes","volume":"160","author":"Arango","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1192\/bjp.bp.108.059717","article-title":"Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis","volume":"195","author":"Arnone","year":"2009","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/(SICI)1098-2396(199806)29:2<142::AID-SYN5>3.0.CO;2-7","article-title":"Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach","volume":"29","author":"Breier","year":"1998","journal-title":"Synapse"},{"issue":"5","key":"10.1016\/j.schres.2015.01.043_bb0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biopsych.2010.10.004","article-title":"Proton magnetic resonance spectroscopy and illness stage in schizophrenia\u2014a systematic review and meta-analysis","volume":"69","author":"Brugger","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2015.01.043_bb0070","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1176\/ajp.155.6.751","article-title":"Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome","volume":"155","author":"Buchanan","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.01.043_bb0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2009.07.015","article-title":"FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia","volume":"114","author":"Buchsbaum","year":"2009","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0080","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.neuroimage.2007.08.049","article-title":"Cortical folding abnormalities in schizophrenia patients with resistant auditory hallucinations","volume":"39","author":"Cachia","year":"2008","journal-title":"NeuroImage"},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0085","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.psychres.2011.04.011","article-title":"Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population","volume":"188","author":"Cadenhead","year":"2011","journal-title":"Psychiatry Res."},{"issue":"7","key":"10.1016\/j.schres.2015.01.043_bb0090","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia\u2014implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000017294","article-title":"Dopamine and N-methyl-d-aspartate receptor interactions in the neostriatum","volume":"20","author":"Cepeda","year":"1998","journal-title":"Dev. Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2015.01.043_bb0100","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1176\/appi.ajp.158.4.518","article-title":"Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials","volume":"158","author":"Chakos","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00213-005-2174-x","article-title":"Predictors and markers of clozapine response","volume":"179","author":"Chung","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.schres.2015.01.043_bb0110","first-page":"CD006324","article-title":"Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia","volume":"3","author":"Cipriani","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.schres.2015.01.043_bb0115","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0006-3223(01)01271-9","article-title":"Management of treatment resistance in schizophrenia","volume":"50","author":"Conley","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/026988110401800315","article-title":"The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study","volume":"18","author":"Conley","year":"2004","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.schres.2015.01.043_bb0125","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0006-3223(91)90132-6","article-title":"High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients","volume":"29","author":"Coppens","year":"1991","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.brainresrev.2005.09.002","article-title":"Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate\u2013putamen and nucleus accumbens of \u201cintact\u201d animals","volume":"50","author":"David","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"11","key":"10.1016\/j.schres.2015.01.043_bb0140","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","article-title":"Dopamine synthesis capacity in patients with treatment-resistant schizophrenia","volume":"169","author":"Demjaha","year":"2012","journal-title":"Am. J. Psychiatry."},{"issue":"5","key":"10.1016\/j.schres.2015.01.043_bb0135","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejrad.2003.08.009","article-title":"High-field proton MRS of human brain","volume":"48","author":"Di Costanzo","year":"2003","journal-title":"Eur. J. Radiol."},{"issue":"7","key":"10.1016\/j.schres.2015.01.043_bb0150","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00330-006-0546-1","article-title":"Proton MR spectroscopy of the brain at 3T: an update","volume":"17","author":"Di Costanzo","year":"2007","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00213-007-0774-3","article-title":"Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics","volume":"193","author":"Didriksen","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0160","first-page":"438","article-title":"Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review","volume":"20","author":"Ebdrup","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.schres.2015.01.043_bb0165","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1176\/appi.ajp.2008.07101562","article-title":"The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis","volume":"165","author":"Ellison-Wright","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2015.01.043_bb0170","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/schbul\/sbt137","article-title":"Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification","volume":"39","author":"Farooq","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pscychresns.2006.12.011","article-title":"A preliminary fMRI study of the effects on cortical activation of the treatment of refractory auditory hallucinations with rTMS","volume":"155","author":"Fitzgerald","year":"2007","journal-title":"Psychiatry Res."},{"issue":"9","key":"10.1016\/j.schres.2015.01.043_bb0180","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0006-3223(91)90053-O","article-title":"Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia","volume":"29","author":"Friedman","year":"1991","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/schbul\/sbr180","article-title":"Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F\/(11) C]-DOPA PET studies","volume":"39","author":"Fusar-Poli","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2015.01.043_bb0190","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ejrad.2011.03.002","article-title":"Improvement of auditory hallucinations and reduction of primary auditory area's activation following TMS","volume":"81","author":"Giesel","year":"2012","journal-title":"Eur. J. Radiol."},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.01.043_bb0195","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0165-0173(99)00049-1","article-title":"Gating of information flow within the limbic system and the pathophysiology of schizophrenia","volume":"31","author":"Grace","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbr.2007.06.012","article-title":"Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat","volume":"184","author":"Grayson","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.schres.2015.01.043_bb0205","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2005.07.002","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol","volume":"519","author":"Hashimoto","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(98)00113-3","article-title":"Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia","volume":"35","author":"Hietala","year":"1999","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2015.01.043_bb0215","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/npp.2013.294","article-title":"Altered interhemispheric and temporal lobe white matter microstructural organization in severe chronic schizophrenia","volume":"39","author":"Holleran","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0230","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2015.01.043_bb0235","doi-asserted-by":"crossref","first-page":"s13","DOI":"10.1192\/bjp.191.51.s13","article-title":"Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis","volume":"51","author":"Howes","year":"2007","journal-title":"Br. J. Psychiatry Suppl."},{"issue":"22","key":"10.1016\/j.schres.2015.01.043_bb0220","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.2174\/138161209788957528","article-title":"Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging","volume":"15","author":"Howes","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.schres.2015.01.043_bb0225","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0240","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00213-004-2058-5","article-title":"Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat","volume":"179","author":"Idris","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0245","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuropsychologia.2008.08.006","article-title":"Clinical practice of rTMS reveals a functional dissociation between agency and hallucinations in schizophrenia","volume":"47","author":"Jardri","year":"2009","journal-title":"Neuropsychologia"},{"issue":"10","key":"10.1016\/j.schres.2015.01.043_bb0250","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2015.01.043_bb0255","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0265","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.01.043_bb0270","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2015.01.043_bb0275","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0006-3223(00)00976-8","article-title":"Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia","volume":"48","author":"Kegeles","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2015.01.043_bb0280","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00406-012-0368-x","article-title":"Individualized rTMS neuronavigated according to regional brain metabolism ((18)FGD PET) has better treatment effects on auditory hallucinations than standard positioning of rTMS: a double-blind, sham-controlled study","volume":"263","author":"Klirova","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.01.043_bb0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0920-9964(00)00130-4","article-title":"Prefrontal cortical sulcal widening associated with poor treatment response to clozapine","volume":"48","author":"Konicki","year":"2001","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2015.01.043_bb0290","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.biopsych.2008.06.011","article-title":"Capitalizing on extrasynaptic glutamate neurotransmission to treat antipsychotic-resistant symptoms in schizophrenia","volume":"64","author":"Krystal","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0295","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2015.01.043_bb0300","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pnpbp.2013.11.015","article-title":"Source-based morphometry of gray matter volume in patients with schizophrenia who have persistent auditory verbal hallucinations","volume":"50","author":"Kubera","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0305","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0306-4522(00)00480-2","article-title":"Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum","volume":"102","author":"Kulagina","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.schres.2015.01.043_bb0310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0079-6123(08)00910-2","article-title":"Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis","volume":"172","author":"Kuroki","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.schres.2006.02.019","article-title":"Neuronavigated transcranial magnetic stimulation and auditory hallucinations in a schizophrenic patient: monitoring of neurobiological effects","volume":"84","author":"Langguth","year":"2006","journal-title":"Schizophr. Res."},{"issue":"17","key":"10.1016\/j.schres.2015.01.043_bb0320","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0325","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/schbul\/sbp099","article-title":"Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting","volume":"37","author":"Leung","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2015.01.043_bb0330","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S1054-3589(08)60850-9","article-title":"Dopamine modulation of responses mediated by excitatory amino acids in the neostriatum","volume":"42","author":"Levine","year":"1998","journal-title":"Adv. Pharmacol."},{"issue":"7","key":"10.1016\/j.schres.2015.01.043_bb0335","first-page":"1349","article-title":"A case report on the relationship between treatment-resistant childhood-onset schizophrenia and an abnormally enlarged cavum septum pellucidum combined with cavum vergae","volume":"125","author":"Liao","year":"2012","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"12","key":"10.1016\/j.schres.2015.01.043_bb0345","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1176\/ajp.151.12.1744","article-title":"Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome","volume":"151","author":"Lieberman","year":"1994","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0340","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/pr.107.00107","article-title":"Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection","volume":"60","author":"Lieberman","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.schres.2015.01.043_bb0350","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1004640408501","article-title":"Treatment refractory schizophrenia","volume":"71","author":"Lindenmayer","year":"2000","journal-title":"Psychiatr. Q."},{"issue":"10","key":"10.1016\/j.schres.2015.01.043_bb0355","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.npp.1301356","article-title":"Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat","volume":"32","author":"Lopez-Gil","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.schres.2015.01.043_bb0365","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","article-title":"NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers","volume":"14","author":"Malhotra","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0360","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.schres.2015.01.043_bb0370","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1176\/appi.ajp.2007.06091479","article-title":"Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study","volume":"164","author":"Mamo","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0375","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/schbul\/sbr069","article-title":"Glutamate in schizophrenia: a focused review and meta-analysis of (1)H-MRS studies","volume":"39","author":"Marsman","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"8","key":"10.1016\/j.schres.2015.01.043_bb0380","first-page":"892","article-title":"Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients","volume":"41","author":"Meltzer","year":"1990","journal-title":"Hosp. Community Psychiatry"},{"key":"10.1016\/j.schres.2015.01.043_bb0385","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.schres.2015.01.043_bb0395","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1176\/ajp.153.10.1343","article-title":"SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine","volume":"153","author":"Molina Rodriguez","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0390","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0925-4927(97)00057-7","article-title":"Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study","volume":"76","author":"Molina Rodriguez","year":"1997","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0400","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0920-9964(96)00115-6","article-title":"Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study","volume":"25","author":"Molina Rodriguez","year":"1997","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0410","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0925-4927(03)00108-2","article-title":"Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia","volume":"124","author":"Molina Rodriguez","year":"2003","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0405","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-004-1981-9","article-title":"Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement","volume":"178","author":"Molina Rodriguez","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"issue":"4","key":"10.1016\/j.schres.2015.01.043_bb0415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2007-984399","article-title":"Marked hypofrontality in clozapine-responsive patients","volume":"40","author":"Molina Rodriguez","year":"2007","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.01.043_bb0420","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.pnpbp.2007.12.028","article-title":"Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients","volume":"32","author":"Molina Rodriguez","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0425","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1755-5949.2010.00222.x","article-title":"Antipsychotic occupancy of dopamine receptors in schizophrenia","volume":"17","author":"Nord","year":"2011","journal-title":"CNS Neurosci. Ther."},{"issue":"10","key":"10.1016\/j.schres.2015.01.043_bb0430","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1176\/ajp.152.10.1444","article-title":"D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients","volume":"152","author":"Nordstrom","year":"1995","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2015.01.043_bb0435","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0440","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/JCP.0b013e31823f913e","article-title":"Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial","volume":"32","author":"Remington","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.schres.2015.01.043_bb0445","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/syn.20623","article-title":"Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response","volume":"63","author":"Roberts","year":"2009","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0450","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biopsych.2008.01.010","article-title":"Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery","volume":"64","author":"Samaha","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0455","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/schbul\/18.1.115","article-title":"Relapse of paranoid psychotic state in methamphetamine model of schizophrenia","volume":"18","author":"Sato","year":"1992","journal-title":"Schizophr. Bull."},{"issue":"1\u20132","key":"10.1016\/j.schres.2015.01.043_bb0460","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0925-4927(02)00065-3","article-title":"Right prefrontal rTMS treatment for refractory auditory command hallucinations\u2014a neuroSPECT assisted case study","volume":"116","author":"Schreiber","year":"2002","journal-title":"Psychiatry Res."},{"issue":"14","key":"10.1016\/j.schres.2015.01.043_bb0465","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1073\/pnas.97.14.7673","article-title":"Schizophrenia: more dopamine, more D2 receptors","volume":"97","author":"Seeman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2015.01.043_bb0470","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neubiorev.2014.06.005","article-title":"Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies","volume":"45","author":"Selvaraj","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.schres.2015.01.043_bb0475","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0166-2236(00)01817-8","article-title":"Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?","volume":"24","author":"Sharp","year":"2001","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.schres.2015.01.043_bb0480","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/schbul\/sbr004","article-title":"Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review","volume":"38","author":"Sommer","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2015.01.043_bb0485","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.188.6.510","article-title":"Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies","volume":"188","author":"Steen","year":"2006","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.01.043_bb0490","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0447.2009.01389.x","article-title":"Morphology of the corpus callosum in treatment-resistant schizophrenia and major depression","volume":"120","author":"Sun","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.schres.2015.01.043_bb0500","first-page":"32","article-title":"Factors associated with response to clozapine in schizophrenia: a review","volume":"44","author":"Suzuki","year":"2011","journal-title":"Psychopharmacol. Bull."},{"issue":"1\u20132","key":"10.1016\/j.schres.2015.01.043_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2012.02.013","article-title":"Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation","volume":"197","author":"Suzuki","year":"2012","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0510","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002130050822","article-title":"In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol","volume":"141","author":"Tauscher","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"issue":"9","key":"10.1016\/j.schres.2015.01.043_bb0505","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1176\/appi.ajp.161.9.1620","article-title":"Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics","volume":"161","author":"Tauscher","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0515","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/JCP.0b013e318218d339","article-title":"Predicting dopamine D(2) receptor occupancy from plasma levels of antipsychotic drugs: a systematic review and pooled analysis","volume":"31","author":"Uchida","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.schres.2015.01.043_bb0520","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jpsychires.2009.12.011","article-title":"Functional connectivity of the temporo-parietal region in schizophrenia: effects of rTMS treatment of auditory hallucinations","volume":"44","author":"Vercammen","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2015.01.043_bb0525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1196\/annals.1300.004","article-title":"Electrophysiological interactions between striatal glutamatergic and dopaminergic systems","volume":"1003","author":"West","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.schres.2015.01.043_bb0535","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1503\/jpn.110008","article-title":"Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations","volume":"36","author":"Wolf","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.01.043_bb0530","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.schres.2011.11.018","article-title":"Magnetic resonance perfusion imaging of auditory verbal hallucinations in patients with schizophrenia","volume":"134","author":"Wolf","year":"2012","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2015.01.043_bb0540","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S1461145799001480","article-title":"Differential changes in glutamatergic transmission via N-methyl-d-aspartate receptors in the hippocampus and striatum of rats behaviourally sensitized to methamphetamine","volume":"2","author":"Yamamoto","year":"1999","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2015.01.043_bb0545","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pnpbp.2013.04.019","article-title":"White matter deficits in first episode schizophrenia: an activation likelihood estimation meta-analysis","volume":"45","author":"Yao","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.01.043_bb0550","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.schres.2012.06.027","article-title":"Antipsychotics, dopamine D(2) receptor occupancy and clinical improvement in schizophrenia: A meta-analysis","volume":"140","author":"Yilmaz","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2015.01.043_bb0555","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00004850-200303000-00008","article-title":"Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia","volume":"18","author":"Yoshimura","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.01.043_bb0560","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.schres.2013.05.002","article-title":"Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia","volume":"148","author":"Zugman","year":"2013","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415000730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415000730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T01:22:53Z","timestamp":1747617773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996415000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":112,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0920996415000730"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.01.043","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroimaging findings in treatment-resistant schizophrenia: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}